Clinical characteristics and prognostic implications in patients with HER2-low breast cancer undergoing neoadjuvant chemotherapy: a retrospective cohort study

被引：0
|
作者：
Zheng, Ang [1 ]
He, Junlin [2 ]
Li, Muyao [1 ]
Yao, Fan [1 ]
Jin, Feng [1 ]
Chen, Bo [1 ]
Wang, Xin [2 ]
机构：
[1] China Med Univ, Hosp 1, Shenyang, Peoples R China
[2] China Med Univ, Shenyang, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词：
HER2; Low; Breast Cancer;
D O I：
10.1016/j.lanwpc.2024.101378
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis
    Xia, Lin-Yu
    Cao, Xu-Chen
    Yu, Yue
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [42] Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer
    Yoshida, Atsushi
    Hayashi, Naoki
    Suzuki, Koyu
    Takimoto, Masafumi
    Nakamura, Seigo
    Yamauchi, Hideko
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) : 1021 - 1028
  • [43] HER2-low expression in breast oncology: treatment implications in the smart chemotherapy era
    Giugliano, Federica
    Curigliano, Giuseppe
    Tarantino, Paolo
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2023, 32 (02) : 149 - 154
  • [44] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Mengdi Chen
    Weilin Chen
    Deyue Liu
    Weiguo Chen
    Kunwei Shen
    Jiayi Wu
    Li Zhu
    Breast Cancer, 2022, 29 : 844 - 853
  • [45] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Chen, Mengdi
    Chen, Weilin
    Liu, Deyue
    Chen, Weiguo
    Shen, Kunwei
    Wu, Jiayi
    Zhu, Li
    BREAST CANCER, 2022, 29 (05) : 844 - 853
  • [46] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Xin Yang
    Yao Li
    Xu lu
    Xiaotian Ren
    Bin Hua
    BMC Cancer, 23 (1)
  • [47] Insights Into the Emerging Entity of HER2-Low Breast Cancer
    El Haddad, Georges
    Diab, Ernest
    Hajjar, Michel
    Aoun, Maroun
    Mallat, Farid
    Zalaquett, Ziad
    Kourie, Hampig-Raphael
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2024, 2024
  • [48] Clinical observation of neoadjuvant chemotherapy with pyrotinib plus trastuzumab in HER2-positive breast cancer: a cohort study
    Li, Qi
    Wang, Yanyan
    Zhu, Mingzhi
    Gu, Yuanting
    Tang, Yajing
    GLAND SURGERY, 2021, 10 (12) : 3389 - 3402
  • [49] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Yang, Xin
    Li, Yao
    Lu, Xu
    Ren, Xiaotian
    Hua, Bin
    BMC CANCER, 2023, 23 (01)
  • [50] Evolution and prognostic significance of HER-2 conversion from primary to residual disease in HER-2 negative patients with breast cancer after neoadjuvant chemotherapy
    Chen, Xi
    Ji, Lei
    Qian, Xiaoyan
    Xiao, Min
    Li, Qing
    Wang, Jiayu
    Fan, Ying
    Luo, Yang
    Lan, Bo
    Chen, Shanshan
    Ma, Fei
    Xu, Binghe
    Zhang, Pin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (08):
12345